Hydrocortisone in very preterm neonates for BPD prevention: meta-analysis and effect size modifiers

Overview of attention for article published in Archives of Disease in Childhood -- Fetal & Neonatal Edition, January 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 15 X posts from 14 X users, with an upper bound of 29,283 followers.

RT @ADC_BMJ: Hydrocortisone in very preterm neonates for BPD prevention Did not reduce BPD Benefits on some secondary outcomes, mortality…

RT @ADC_BMJ: Hydrocortisone in very preterm neonates for BPD prevention Did not reduce BPD Benefits on some secondary outcomes, mortality…

RT @ADC_BMJ: Hydrocortisone in very preterm neonates for BPD prevention Did not reduce BPD Benefits on some secondary outcomes, mortality…

RT @ADC_BMJ: Hydrocortisone in very preterm neonates for BPD prevention Did not reduce BPD Benefits on some secondary outcomes, mortality…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.